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Abstract
Background: Cancer is highly prevalent worldwide and can cause high levels of distress in patients, which is often neglected
in medical care. Smartphone apps are readily available and therefore seem promising to deliver distress-reducing interventions
such as mindfulness and relaxation programs.
Objective: This study aimed to evaluate the feasibility of a mindfulness and relaxation app for cancer patients. We looked at
characteristics of participating patients in a mobile health (mHealth) study, including adherence to the app intervention, predictors
for adherence, and patients’ feedback regarding the app.
Methods: In this prospective observational study with a mixed-methods approach, cancer patients received a mindfulness and
relaxation self-care app. Cancer patients were recruited online and through hospitals in Switzerland. We assessed self-reported
measures (eg, quality of life, anxiety, depressive symptoms, openness to experience, resistance to change) at baseline, and the
app gathered data on patients’ practicing time. With 8 semistructured interviews, we obtained patients’ feedback about the app
and recommendations for improvements. We looked at 3 dimensions of the Reach, Effectiveness, Adoption, Implementation,
and Maintenance framework (reach, adoption, and maintenance) and analyzed data for adherence for the first 10 weeks of the
app intervention. We report descriptive statistics for patient characteristics and app use. For the prediction of adherence, we used
Kaplan-Meier analyses with log-rank tests and a Cox proportional hazards regression.
Results: Data from 100 cancer patients (74 female) showed that 54 patients were using the app exercises continuously until
week 10. In continuous app users, the median number of exercises per week dropped from 4 (interquartile range, IQR 1-7) at
week 1 to a median of 2 (IQR 1-4) at week 10. Our analyses revealed 4 significant predictors for better adherence: female gender,
higher openness to experience, higher resistance to change, and more depressive symptoms. Interviews revealed that the patients
generally were satisfied with the app but also made suggestions on how to improve it.
Conclusions: Our study indicates that a mindfulness and relaxation mHealth intervention for cancer patients is feasible with
acceptable adherence and largely positive feedback from patients.
Trial Registration: German Clinical Trials Register DRKS00010481; https://www.drks.de/drks_web/navigate.do?navigation
Id=trial.HTML&TRIAL_ID=DRKS00010481 (Archived by WebCite at http://www.webcitation.org/73xGE1B0P)
(JMIR Mhealth Uhealth 2018;6(12):e11271)   doi:10.2196/11271
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Introduction
Background
Cancer is highly prevalent worldwide, with an estimated 14
million newly diagnosed patients per year [1]. According to the
World Health Organization, cancer is the second leading cause
of death, with an increasing economic impact over recent years
[2]. For patients, the diagnosis of cancer and subsequent
treatment (eg, radiation or chemotherapy) can cause high levels
of distress [3,4]. About every second cancer patient has clinically
relevant distress, with elevated levels of depression or anxiety
[5]. However, psychological support of patients is often not
implemented in standard medical care [6-8]. In addition, many
patients neglect their distress and do not seek psychosocial
support [9]. However, untreated distress can reduce quality of
life as well as lower adherence with recommended medical care
and, therefore, negatively affect patients’ recovery [8,10]. Thus,
a variety of treatments such as counseling and Mind Body
Medicine (MBM) interventions have been suggested to reduce
cancer patients’ distress during initial care and rehabilitation
[11-13].
MBM focuses on the interactions between psychological and
biological processes and their impact on health [14,15] and has
shown beneficial effects in reducing cancer patients’ distress
[13,16]. MBM usually combines a variety of interventions, such
as exercise, Qigong, relaxation, and mindfulness meditation
[14]. Some of these interventions, for example, mindfulness
and relaxation, are also commonly used on their own and have
been studied extensively with promising effects in both healthy
and patient populations [15,17-20]. In addition, an increasing
number of cancer patients are interested in or use mindfulness
or relaxation interventions [21].
Regular practice is crucial for the effect of mindfulness and
relaxation-based interventions, which can be difficult to achieve
due to lack of motivation, time constraints, as well as limited
access to interventions [22]. Further restrictions for regular
practice and access-limiting factors include geographical
distance, financial constraints, lack of treatment providers or
lack of knowledge thereof [8,9,23]. For cancer patients, regular
practice might additionally be hindered due to restrictions caused
by cancer (eg, fatigue and nausea) and its comprehensive
treatments.
Mobile health (mHealth) interventions might overcome some
of the restrictions of face-to-face interventions. The access to
interventions can be easier due to a large and increasing number
of smartphone owners [24]. In 2017, more than 32% of the
world population and more than 60% of the population in
Western Europe and North America owned a smartphone [25].
In addition, mHealth interventions have some specific
advantages compared with face-to-face interventions. These
advantages include easy and pervasive access to information
(ie, psychoeducation), engaging audio and/or visual material,
potential customization of the app according to client’s
preferences and needs, provision of regular feedback, reminders,
and reduced perceived stigmatization due to potentially less
therapist contact [24,26]. mHealth interventions can also be a
good support for patients’ self-care [26]. Such self-care
interventions can have beneficial effects on cancer patients’
distress and quality of life [27] and can be implemented via an
app using audio instructions.
To date, mHealth interventions using a mindfulness or relaxation
intervention strategy have been under-researched, with the focus
of studies primarily on Web-based electronic Health (eHealth)
interventions [28]. For eHealth interventions, studies indicate
that mindfulness- and relaxation-based interventions can have
beneficial effects on health outcomes in various populations,
including cancer patients [28-30]. Beneficial effects of eHealth
were reported for stress, well-being, anxiety, depression, and
mindfulness. The majority of available primary studies in these
reviews focused on eHealth interventions, with a partial
emphasis on Web-based patient-therapist interactions. However,
less is known about the feasibility and effectiveness of mHealth
interventions, and certain disadvantages (eg, technical problems,
concerns about data security) are well known [26]. Eysenbach
[31] coined the term “law of attrition,” which emphasizes that
early and rapid attrition rates are an inherent problem in
technology-delivered interventions. Especially in self-care
interventions with regular exercises, good adherence itself often
becomes an intervention goal. Although recent eHealth studies
report acceptable rates of adherence (eg, 60% completed 4 or
more out of 6 modules [32] and 71% practiced more than 50%
of the days during 8 weeks [33]), little is known about the
adherence to mindfulness and relaxation mHealth programs for
cancer patients. Therefore, when setting up a self-care mHealth
intervention, it is important to know which factors might
influence the patient adherence.
Objective
The aim of this mHealth study, then, was to evaluate the
feasibility of a mindfulness and relaxation app for cancer
patients and its impact on health outcomes according to the
Reach, Effectiveness, Adoption, Implementation, and
Maintenance (RE-AIM) framework [34]. In this analysis, we
looked at the characteristics of patients who participated in this
mHealth study, adherence and predictors for adherence, as well
as patients’ feedback regarding the mHealth intervention from
interviews.
Methods
Study Design
We performed a prospective observational study using a
mixed-methods approach. Quantitative data consisted of 4
paper-and-pencil questionnaires sent to cancer patients at
baseline, weeks 4, 10, and 20. Qualitative data consisted of
semistructured interviews with 8 cancer patients. Corresponding
to the principles of theoretical sampling [35], we recruited the
interviewees based on the sample distributions of gender and
intervention dropouts versus continuous app users. We
conducted individual qualitative interviews over the telephone
with these patients; selecting 4 of them who used the app on a
regular basis and 4 who did not use the app regularly. We
conducted qualitative interviews with these patients; 4 of them
used the app on a regular basis and 4 did not use the app
regularly. This study was guided by the RE-AIM evaluation
framework [34], which consists of the following 5 dimensions:
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 12 | e11271 | p.2https://mhealth.jmir.org/2018/12/e11271/
(page number not for citation purposes)
Mikolasek et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
reach, effectiveness, adoption, implementation, and maintenance.
For this analysis, we focused on 3 dimensions, namely reach,
adoption, and maintenance during the first 10 weeks of the
intervention. The dimensions effectiveness and implementation
as well as results about the entire 20 weeks will be reported in
an upcoming paper. The cantonal ethics committee granted
ethical approval for the study (BASEC-Nr. 2016-00258) in April
2016, and the study was positively audited within the regular
ICH-GCP audit of the University Hospital Zurich in August
2016. We registered the study in the German Clinical Trials
Register (DRKS00010481).
Eligibility Criteria
We included female and male cancer patients (18 years or older)
with any cancer diagnosis at any stage of cancer, who owned
either an iOS- or Android-based smartphone with at least a
weekly connection to the internet. We excluded patients if they
had suicidal ideation or insufficient German language skills.
Furthermore, patients who intended to move to another country
and patients with insufficient knowledge on how to use a
smartphone were excluded.
Recruitment
We recruited cancer patients in 2 different settings: (1) cancer
patients who participated in a supportive MBM treatment (either
as individual session or as a 10-week group treatment) or (2)
cancer patients without an MBM treatment.
For setting 1, cancer patients were recruited at the Institute for
Complementary and Integrative Medicine, University Hospital
Zurich (ICI). All available cancer patients in an MBM group
treatment (between June 2016 and December 2017; 12 groups
with a total of 81 patients) were invited at the third session of
the course to participate in the study. Therefore, enrolled patients
from setting 1 were using the app partially in parallel to the
MBM group treatment. In addition, we asked the health
professionals of the ICI to distribute leaflets during individual
MBM consultations with cancer patients.
For setting 2, patients were recruited through the University
Hospital Zurich (ICI, cancer center, Department of
Radiotherapy, and University Hospital Facebook page),
University Hospital Basel, and the Cantonal Hospital Aarau.
Cancer patients were informed of the study using leaflets in the
waiting areas or during consultations. In addition, we informed
cancer patients through the Swiss Cancer League via leaflets
and their Facebook page, as well as through the Cancer League
of Zurich.
Interested patients initially contacted a researcher at the ICI by
phone or email and made an appointment for a 10-min telephone
screening interview. During the screening interview, the
researcher explained the study and assessed the eligibility of
the patient. In addition, the researcher recommended that the
patient carry out 1 of the 3 exercises of the app at least once a
day on 5 different days per week during the 20-week
intervention. However, the researcher also stated that patients
were free to choose when, where, and how often they practiced.
After the researcher provided all information and if the patient
met the eligibility criteria, the researcher asked for contact
details of the patient. Subsequently, the patient received the
written study information with the informed consent form, as
well as the first questionnaire by mail. We sent an email to every
included patient with a code to activate the app. Thereafter,
patients were able to use the app free of charge. The date of the
code distribution was considered as the start of the intervention
for each patient. No other verbal contact between the researcher
and the patients took place after inclusion of patients.
Intervention
The mindfulness and relaxation app comprised 2 main features:
(1) mindfulness and relaxation exercises guided by audio
instructions and (2) a notification feature. The first feature of
the app contained 3 exercises and was the main component of
the app. The exercises were mindfulness meditation, guided
imagery, and progressive muscle relaxation audio files with a
duration of about 15 min each. Every exercise was guided by
a narrator with either a male or female voice.
The second feature of the app was a notification feature, which
reminded the patient to practice daily. The patient could set the
time of notification according to individual preferences. The
reminder to practice popped up as a push notification on the
mobile device every day at the time set by the patient. The
concept of the app built on previously developed relaxation
study apps of an affiliated group [36], which were designed for
patients with chronic low back pain (Relaxback) and chronic
neck pain (Relaxneck).The app was developed by the software
company Smart Mobile Factory GmbH (Berlin, Germany). After
thorough testing, the app was released in June 2016 on the Apple
iTunes Store and on the Google Play Store for Android devices.
After the release, the content of the app was not changed.
Screenshots of the app are available in Multimedia Appendices
1 and 2.
Outcomes
Reach
For the dimension reach, we looked into which and how many
cancer patients participated in the study. We present baseline
characteristics to describe participating patients: type of cancer,
status of cancer treatment, sociodemographic data (gender, age,
and highest education), distress (Distress-Thermometer [37,38]),
quality of life (FACT-G, Functional Assessment of Cancer
Therapy-General [39]), and anxiety and depression (HADS,
Hospital Anxiety Depression Scale [40]).
The Distress-Thermometer consists of 1 item with a scale from
0 to 10 and assesses experienced distress in the past week. A
score between 5 or higher is considered as clinically relevant
distress [41]. The FACT-G consists of 27 items, which assess
the 4 subscales: physical well-being (Cronbach alpha=.851),
social well-being (Cronbach alpha=.760), emotional well-being
(Cronbach alpha=.702), and functional well-being (Cronbach
alpha=.794). Each item is rated on a 5-point scale (0-4), resulting
in a score range of 0 to 108, with a higher score indicating a
better quality of life. The HADS consists of 14 items, with 7
items for each subscale, that is, anxiety (Cronbach alpha=.787)
and depression (Cronbach alpha=.667). Each item is rated on a
4-point scale (0-3), leading to a maximum score of 21 for each
subscale. A score between 0 and 7 is considered normal, whereas
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a score between 8 and 11 is considered as borderline, and a
score above 11 as caseness.
Adoption
For the dimension adoption, we looked at indicators of patients’
adoption of the app intervention into their regular life,
adherence, and information about barriers and facilitators for
regular use. For this purpose, we analyzed the use of the app
during the first 10 weeks. We derived app use data from tracking
the practicing time with the audios (start and end time and type
of exercise used). This information was visible only for the
research team (as an XML log file through the backend) and
was not displayed to users. In addition, we analyzed results from
interviews with patients regarding their adoption of the app
intervention.
As a first indicator for app intervention adoption, we report the
number of completed app exercises per week. We considered
an exercise as completed if the patient used the exercise for at
least 10 min (out of 15 min). As a second indicator, we report
the number of intervention dropouts versus number of
continuous app users per week. Intervention dropouts were
defined as enrolled patients who never completed an exercise
or did not complete an exercise during 4 consecutive weeks
after initial practice. A patient counted as an intervention dropout
in the first of the 4 weeks, in which he or she did not complete
any exercise. According to our definition, a patient who never
completed an exercise is an intervention dropout at week 1.
Patients not classified as intervention dropouts were defined as
continuous app users. Consequently, continuous app use was
defined as at least weekly use of 1 or more app exercises. We
also report results from 8 semistructured patient interviews, in
which we inquired about patients’ general impression regarding
the app, app usage, and suggestions for improvements (for
interview guideline, see Multimedia Appendix 3).
Maintenance
For the dimension maintenance, we looked into predictors for
continuous app use. First, we assumed that patients with higher
openness to experience are more often continuous app users.
Second, we assumed that patients with higher resistance to
change are less often continuous app users. In addition, we
tested in explorative analyses if quality of life (FACT-G),
anxiety (HADS anxiety), depression (HADS depression) at
baseline and sociodemographic data (gender and age), as well
as setting are associated with continuous app use. During the
interviews, we also explored possible reasons for continuous
app use and intervention dropout.
We measured openness to experience with the respective
subscale of the NEO 5-Factor Inventory (NEO-FFI [42]) using
the 5-item short version (Cronbach alpha=.755). Each item is
rated on a 4-point scale (0-4), leading to a score with a range
from 0 to 20. A higher score indicates greater openness to
experience. We also used the Resistance to Change (RTC) Scale
[43], which consists of 17 items (Cronbach alpha=.839). Each
item is rated on a 6-point scale (1-6), resulting in a score with
a range from 17 to 102. A higher score indicates greater
resistance to change.
Sample Size
In this feasibility study, the sample size is an outcome in itself
(ie, dimension reach in the evaluation framework). Therefore,
we did not perform an a priori sample size calculation, but the
aim was to recruit about 100 patients to conduct explorative
analyses about the feasibility of the app with sufficient precision.
Data Analysis
Quantitative Data
Trained researchers entered data from printed case report forms
using REDCap electronic data capture tools [44] hosted at the
University Hospital Zurich. Analyses were conducted using
SPSS version 25.0 (IBM Corp, Armonk, NY, USA) [45].
For the reach analyses, we used descriptive statistics
(frequencies and percentages for categorical and dichotomous
variables, mean and SD for continuous variables) for baseline
data on sociodemographic characteristics (gender, age, and
education), health status (type of cancer, status of cancer
treatment, FACT-G, HADS, and Distress-Thermometer), and
the setting of the enrolled patients. For the adoption analyses,
we used boxplots to report median and interquartile range (IQR)
of the number of completed exercises per week (week 1 to 10)
for all enrolled patients, as well as for continuous app users
during the 10-week intervention. In addition, we used a
Kaplan-Meier plot to visualize the number of dropouts per week.
For the maintenance analyses, we used Kaplan-Meier analyses
with a log-rank test to compare continuous app users (ie,
reversed rate of attrition) according to different baseline
variables. As predictors, we used the following categorical
variables: gender, setting, age groups (18-40, 41-55, 56+), high
versus low well-being (FACT-G median split at 76.83), high
versus low openness to experience (NEO-FFI-O median split
at 17.00), high versus low resistance to change (RTC median
split at 51.00), normal versus suggestive or higher anxiety or
depression (HADS anxiety or depression scores of 0-7 vs 8 or
higher). Subsequently, we performed a Cox proportional hazards
regression with all significant predictors in the log-rank test in
the Kaplan-Meier analyses.
For missing data, we used multiple imputation to conduct the
Cox proportional hazards regression with a full dataset. We
carried out imputations for the sum scores of FACT-G, as
missing single items are already considered in the calculation
of FACT-G sum scores (FACT-G sum scores are not calculated
if there are more than 50% items missing in a subscale). For
HADS, NEO-FFI-O, and RTC, we imputed all items with 1 or
more missing values. For all other analyses (ie, descriptive
analyses for the dimensions reach and adoption, Kaplan-Meier
analyses for the dimension maintenance), we used complete
datasets.
Qualitative Data
For the interview analyses about the adoption and maintenance
of the intervention, we transcribed the recorded interviews
verbatim and used thematic coding for structuring the interviews
using MAXQDA 11 (VERBI Software, Berlin, Germany).
Thereafter, we used content analysis according to Mayring [46].
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Results
Reach
During the recruitment phase between June 2016 and December
2017, a total of 118 patients expressed interest in participating
in the study and were screened for eligibility. All of the 118
patients fulfilled the eligibility criteria and received the informed
consent form. By the end of December 2017, 100 patients signed
and returned the informed consent form and were enrolled in
the study (see Figure 1).
Baseline characteristics of all enrolled patients (N=100), as well
as of continuous app users (54/100, 54%) and intervention
dropouts (46/100, 46%) are presented in Table 1. The majority
of patients (83/100, 83%) were recruited independent of the
MBM treatment (setting 2). Patients were 74% (74/100) female,
and the mean age of all patients was 53.24 (SD 11.55) with a
range of 23 to 84 years. The most common diagnosis was breast
cancer (39/100, 39%). The majority of participants had
completed higher education, whereas 41% (41/100) had
completed secondary education and 33% (33/100) had obtained
a university degree. The Distress-Thermometer indicated that
the enrolled patients reported, on average, elevated and clinically
relevant distress levels. The HADS scores indicated that the
enrolled patients had, on average, normal scores of anxiety and
depressive symptoms. Continuous app users and intervention
dropouts differed in their gender, with 85% (46/85) female
continuous app users versus 61% (28/61) female intervention
dropouts.
Figure 1. Patient flowchart. FMI: Freiburg Mindfulness Inventory; PROMIS 29: Patient Reported Outcomes Measurement Information System 29;
NEO-FFI-O: NEO Five-Factor Inventory - openness to experience; FACT-G: Functional Assessment of Cancer Therapy-General; RTC: Resistance to
Change; FoP-Q-SF: Fear of Progression Questionnaire - Short Form; HADS: Hospital Anxiety Depression Scale.
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Table 1. Baseline characteristics of all enrolled patients, continuous app users, and intervention dropouts.
Intervention dropouts (n=46)Continuous app users (n=54)Total (N=100)Baseline characteristics
Gender, n (%)
28 (61)46 (85)74 (74)Female
18 (39)8 (15)26 (26)Male
51.45 (11.74)54.77 (11.27)53.24 (11.55)Age (years), mean (SD)
Type of cancer, n (%)
13 (28)26 (48)39 (39)Breast cancer
5 (11)4 (7)9 (9)Colon cancer
0 (0)6 (11)6 (6)Ovarian or cervical cancer
1 (2)5 (9)6 (6)Lung cancer
27 (59)13 (24.)40 (40)Others
Status of cancer treatment, n (%)
20 (44)26 (48)46 (46)Total removal
13 (28)12 (22)25 (25)Recurrence or incomplete removal
1 (2)2 (4)3 (3)Uncertain
12 (26)14 (26)26 (26)Others
Highest education, n (%)
1 (2)2 (4)3 (3)Primary school
12 (26)10 (19)22 (22)Apprenticeship
17 (37)24 (44)41 (41)Secondary education
16 (35)17 (32)33 (33)University degree
0 (0)0 (0)1 (1)Unknown
Setting, n (%)
8 (17)9 (17)17 (17)Setting 1a
38 (83)45 (83)83 (83)Setting 2b
5.22 (2.14)5.36 (2.47)5.29 (2.31)Distress-Thermometer, mean (SD)
74.33 (13.63)76.56 (14.08)75.54 (13.85)FACT-Gc Quality of life, mean (SD)
6.53 (3.38)7.17 (3.60)6.88 (3.50)HADSd anxiety, mean (SD)
4.48 (2.37)5.37 (3.05)4.96 (2.78)HADS depression, mean (SD)
aSetting 1: cancer patients with a supportive Mind Body Medicine treatment.
bSetting 2: cancer patients without a supportive Mind Body Medicine treatment.
cFACT-G: Functional Assessment of Cancer Therapy-General.
dHADS: Hospital Anxiety Depression Scale.
Adoption
The number of app exercises completed within the first 10 weeks
of the intervention across all patients is presented in Figure 2.
During the first week, the median of completed exercises was
at 2 with an IQR of 0 to 6, that is, 50% of patients completed 2
or more exercises per week. Over the course of 10 weeks, the
median dropped to 0 with an IQR of 0 to 2.5.
The median of app exercises completed across the first 10 weeks
of the intervention for continuous app users is presented in
Figure 3. During the first week, the median of completed
exercises was 4 (IQR 1-7) and dropped down to a median of 2
(IQR 1-4) in week 10.
The Kaplan-Meier survival curve of continuous app users is
presented in Figure 4. During the first week, 14/100 (14%)
patients never started or stopped using the app exercises on a
regular basis and were categorized at week 1 as intervention
dropouts. At the end of the intervention, 54/100 (54%) patients
were using the app exercises on a regular basis, and between
week 1 and week 10, the decline can be regarded as continuous
without any specific sensitive weeks to drop out.
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Figure 2. Completed app exercises by all patients who were enrolled in the study (N=100) per week (median, interquartile range).
Figure 3. Completed app exercises by continuous app users within a 10-week app intervention (n=54) per week (median, interquartile range).
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Figure 4. Kaplan-Meier survival curve of all enrolled patients (N=100) over 10 weeks.
Maintenance
The Kaplan-Meier plots for intervention dropouts by gender,
setting, age groups, and well-being are presented in Figure 5.
The Kaplan-Meier plots for intervention dropouts by openness
to experience, resistance to change, anxiety, and depression are
presented in Figure 6. Log-rank tests indicated 4 significant
predictors for continuous app users, namely gender, openness
to experience, resistance to change, and depression.
At week 10, 62% (46/74) of the female patients were still using
the app continuously, whereas only 31% (8/26) of the male
patients were using the app continuously. Therefore, females
had a better adherence to use the app continuously over time
than men (P=.005). In the high openness to experience group
(NEO-FFI-O), 67% (28/42) of patients still used the app
continuously through week 10. In the NEO-FFI-O low openness
group, 44% (24/54) used the app continuously through week
10. Thus, patients with high openness to experience had a better
adherence than patients with low openness to experience over
time (P=.044). In patients with normal HADS depression values,
only 49% (39/80) used the app exercises continuously compared
with 75% (15/20) in the HADS suggestive or higher depression
group (P=.046). In patients with high RTC, 65% (28/43) used
the app exercises continuously, but in the low RTC group, only
44% (23/52)of patients used the app exercises continuously
through week 10. Therefore, patients in the high RTC group
had a better adherence in continuous app use (P=.03). For the
factors setting, age groups, well-being (FACT-G), anxiety
(HADS anxiety), log-rank tests did not result in significant
group differences.
The 4 significant factors of the univariate log-rank test (gender,
NEO-FFI-O, RTC, HADS depression) for the prediction of
continuous app users went into the multivariate Cox proportional
hazards regression. The multivariate analysis indicated solely
gender as an independent factor for continuous app use, with
an odds ratio (OR) of 2.16 (95% CI 1.09 to 4.27), with a higher
chance for attrition in male cancer patients (P=.01). The 3 other
factors (NEO-FFI-O, RTC, and HADS depression) did not
contribute significantly in this analysis after controlling for
gender: high openness to experience was associated with lower
odds for attrition (OR 0.96; 95% CI 0.89 to 1.04; P=.30); high
RTC with lower odds for attrition (OR 0.98, 95% CI 0.95 to
1.01; P=.17); more depressive symptoms with lower odds for
attrition (OR 0.92, 95% CI: 0.80 to 1.03; P=.13).
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Figure 5. Kaplan-Meier survival curves for continuous app users by gender, setting, age groups and well-being. FACT-G: Functional Assessment of
Cancer Therapy-General.
Figure 6. Kaplan-Meier survival curves for continuous app users by openness to experience, resistance to change, anxiety and depression. NEO-FFI-O:
NEO Five-Factor Inventory - openness to experience; RTC: Resistance to Change; HADS: Hospital Anxiety Depression Scale.
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Qualitative Results
We invited 8 patients (2 from setting 1, 7 female, mean age
50.70 years (SD 15.06), 3 with breast cancer) to an interview,
and all agreed to take part. Interviews were conducted between
October 2016 and April 2017 and lasted on average 23 min.
The qualitative analysis of the interviews yielded 4 themes
which were as follows: (1) general feedback regarding the app,
(2) suggestions for improvement, (3) personal preferences, and
(4) reasons for app use and nonuse.
General feedback about the app was predominantly positive.
The interviewed patients appreciated the simplicity of the app
and the easy-to-use interface. One patient stated the following
regarding the design:
It was great. It was very simple, very self-explanatory.
You didn’t need to look around a lot and it also looked
good. Yes, in any case, well designed. [Female, 35
years old]
Two patients who attended an MBM course evaluated the app
as a good addition to the face-to-face MBM course. The
feedback about the number of exercises was mixed: Some
patients regarded the implemented 3 exercises as sufficient,
whereas others would welcome a larger selection of exercises.
Most patients interviewed used and appreciated the reminder
in the app. Some patients mentioned that they would have been
less compliant without the reminders and, therefore, perceived
the reminder as helpful for a continuous app use. For instance,
1 patient stated the following:
Yes, [the reminder function] was very good. A couple
of times this was very good. I would have forgotten
it a couple of times, if I wouldn’t have had this
reminder. [Female, 63 years old]
Patients offered various suggestions for improvement. Several
patients mentioned that they would like exercises with
background music. One patient explained it as follows:
I think it is also precisely the high art of meditation
or relaxation that you can relax as much as possible
while not falling asleep. Some need chimes, while
others need absolute silence to be able to do this. And
I realize that when it is absolutely silent, either I fall
asleep or I start to contemplate. When I have some
music or chimes, it works better for me personally.
[Female, 42 years old]
As stated above, some patients also would welcome a larger
variety of exercises (eg, autogenic training) or variations in the
duration of exercises. Another patient stated also that the
recordings of the exercises were too clean (ie, no noises from
breathing), as the exercises were recorded in a studio. This led
to the patient being startled when the narrator continued with
the instruction after a moment of silence. One patient mentioned
she did not set up the reminder during the first time she used
the app and later forgot about the reminder function. Therefore,
this patient suggested that the reminder function could be placed
more prominently in the app instead of the options menu. The
interviewer also inquired if the patients would appreciate a
feedback system in the form of exercise statistics. The majority
of interviewed patients had the opinion that such a feature would
not be helpful. Some patients stated that statistics might even
be stressful, as it might lead to a guilty conscience if the patient
is not using the exercises as often as planned. One patient
suggested that statistics might be added to the app as an optional
feature. Only 2 patients thought that such a feature might be
helpful.
The third topic that emerged from the qualitative analysis was
personal preferences. Most interviewed patients mentioned that
they developed some form of preference regarding the app use
(eg, preference for a specific exercise, gender of narrator, time
of day when using the exercises) during the intervention while
they were trying out what suits them best. One patient stated
the following:
Right at the beginning I tried [to do the exercises]
before I went to bed. But I’m not a fan of having my
cellphone, when I fall asleep, next to my head for the
entire night. For this reason I changed it to lunchtime.
[Female, 31 years old]
The fourth topic that emerged from the qualitative analysis
involved reasons for app use and nonuse. As a reason for using
the app, patients mentioned that the exercises were beneficial
and helped them to relax. One patient stated the following:
[The app exercises] have been good for me. I will
continue to do my exercises. […] I believe I benefit
[from the exercises]. It also makes you happy.
[Female, 63 years old]
As reasons for nonuse, 3 patients mentioned that they had
previous experience with meditation or relaxation exercises.
Therefore, these patients were already used to exercise routines,
which differed from the instructions or the manner in general
of the app exercises. One of these patients mentioned that she
had learned and was used to silent meditation, and therefore the
guided exercises in the app were more distracting than helpful
to her. Another patient mentioned that she had experience in
guided meditation and relaxation exercises, which differed
linguistically and in form of conduct compared with the app
exercises. This patient mentioned that she was unable to get
used to these new exercises and was repeatedly comparing the
app exercises with the already known exercises. Therefore, this
patient could not relax as intended during the app exercises. A
third patient mentioned that she was used to exercises with more
guidance and described her experience with the app as follows:
Maybe because [the instructions in the app exercises]
were different from what I was used to do by myself,
where [the exercise] was guided the entire time. […]
I did consider it more bothersome that…[…] your
thoughts drift away because you get the feeling that
[the exercise] should continue. [Female, 49 years old]
As a further reason for nonuse, 1 patient mentioned that she
was distracted by the choice of words and expressions in the
app exercises. This patient mentioned that she had studied
linguistics and had learned to closely scrutinize language. This
caused her to be distracted during the app exercises, which is
why she stopped using the app. Another patient mentioned that
she suffered from cancer-related fatigue and that she was not
able to complete an exercise when she was unduly fatigued.
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 12 | e11271 | p.10https://mhealth.jmir.org/2018/12/e11271/
(page number not for citation purposes)
Mikolasek et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Furthermore, 1 patient stated he had technical problems with
his smartphone and therefore was not able to use the app during
the entire 10 weeks.
Discussion
Summary of Findings
mHealth interventions with the aim of reducing distress in cancer
patients seem promising due to easy access and potential positive
effects for patients. To our knowledge, this is one of the first
studies looking in detail at characteristics of users, adherence
rates, and possible predictors for adherence in a mindfulness
and relaxation mHealth study for cancer patients. This feasibility
study showed that adherence to the mHealth intervention during
the first 10 weeks was acceptable, with 54% of patients still
using the app regularly in week 10 with a median of completed
exercises ranging from 2 to 4 per week. Therefore, our study
does not confirm the concern that adherence in mHealth
interventions is in general poor, which would limit treatment
implementation. The adherence of our patients is also
comparable with recent research on adherence to e- and mHealth
interventions for cancer patients [32,33]. A study by Beatty el
al [32] reported that 60% of cancer patients completed 4 or more
modules of an eHealth intervention with 6 modules, which
aimed at reducing distress in cancer patients. A mindfulness
app study for cancer patients and caregivers [33] reported that
71% of the participants practiced with the app on more than
half of the days throughout 8 weeks.
The uptake of our intervention was good, with 117 screened
and eligible patients, of whom 100 patients returned the
informed consent form. In addition, 74%, mainly female,
patients enrolled in this study, which is consistent with
characteristics of mHealth users in other studies with 84%
female patients [47] and 54% female patients [48]. The mean
age of participating patients was 53 years; this is comparable
with other face-to-face mindfulness and relaxation interventions
[49] or Web-based interventions for cancer patients [32]. The
interviews showed that the patients were satisfied with the app
in general. However, several and sometimes contradictory
suggestions were made for improving the app, such as less
versus more guidance in the exercises and larger variety in
exercises versus the notion that 3 exercises are sufficient.
Predictors for Adherence
Of a total of 8 investigated predictors for continuous app use,
4 turned out to be statistically significant. The strongest predictor
was gender, with higher adherence in female cancer patients.
Beyond the higher interest of female cancer patients to
participate in this mindfulness and relaxation mHealth study,
they were also more adherent after starting with the exercises.
This result is in line with a study by Ruland et al [50], in which
an analysis of use patterns in an eHealth intervention to support
cancer patients’ illness management revealed that female patients
used the system almost twice as often as male patients. However,
a study by Duman-Lubberding et al [51] investigated the
feasibility of a Web-based self-management app and did not
find a gender difference in adherence. Therefore, it seems likely
that the type of intervention (eg, relaxation and mindfulness
meditation) might be relevant for gender differences in
adherence, which is also in line with studies about the use of
complementary and alternative medicine, where users tend to
be more often female [52,53].
A second predictor for continuous app use was the personality
trait openness to experience, whereby higher openness to
experience predicted more continuous app use. This result fits
with previous research, which has shown that openness to
experience predicts the use of complementary and alternative
medicine, including mindfulness and relaxation [54,55]. Our
study confirms that higher openness to experience still predicts
the adherence to a mindfulness and relaxation intervention, even
if the intervention is delivered through an app.
A third predictor for continuous app use was a higher score in
resistance to change. This finding is contrary to our hypothesis,
as we assumed that higher resistance to change would be
associated with less adherence as the intervention promotes a
new health behavior. However, our results indicate the opposite.
When a patient has decided to follow a new exercise routine
(ie, mindfulness and relaxation mHealth intervention), a higher
resistance to change actually promotes continuous app use. To
our knowledge, the Resistance to Change Scale had not
previously been used to predict adherence to mHealth
interventions for cancer patients. However, a study conducted
in China by Deng et al [56] showed that resistance to change is
negatively related to the intention to use mHealth services.
Another study showed that resistance to change is negatively
related to perceived usefulness of mHealth in elderly people in
China [57]. Therefore, on the one hand, resistance to change
might be a barrier for the uptake of an mHealth intervention,
but on the other, it might be supportive in adhering to a new
commitment, such as the regular use of a mindfulness and
relaxation app.
A fourth predictor for continuous app use was higher depressive
symptoms. This finding is surprising, as depressive symptoms
are associated with decreased motivation and reduced activity
[58]. In line with these corollaries, a study investigating a
mindfulness-based cancer recovery program [49] reported a
negative correlation of depressive symptoms and practicing
time of yoga at home. Another study [59] reported that moderate
to severe depressive symptoms predicted lower adherence to
adjuvant cancer therapies. However, a study by Børøsund et al
[60] found that high levels of depression were associated with
high use of components of a Web-based illness management
program in breast cancer patients. As depressed patients are
oftentimes troubled with motivational deficits and face
difficulties to stay active, the development of effective
interventions with a good adherence in depressed patients is
highly relevant. Our study indicates that mindfulness and
relaxation mHealth interventions seem a feasible tool as
supportive interventions for cancer patients with elevated
depressive symptoms. This finding might also indicate that some
patients adhere better to mindfulness and relaxation (ie, patients
with higher depressive symptoms), whereas other patient groups
with lower levels of distress are not in need of such interventions
or might prefer other intervention types.
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Limitations
This study has some limitations. First, the number of potentially
interested patients for this intervention could not be assessed.
Therefore, we were not able to calculate the rate of the total
number of eligible cancer patients compared with the number
of cancer patients with interest in a mindfulness and relaxation
mHealth intervention. Second, for our definition of continuous
app, we had no empirical data because the necessary dose for
clinically significant improvements is still unclear for this kind
of mHealth intervention. Instead, we opted for a clinical and
rational justification, in which the term “continuous” use was
operationalized as an at least weekly use of 1 or more app
exercises. Third, the use of generated categories for age and the
median split for other variables as predictors can be challenged.
For age, we chose 3 age categories that represent patients of
younger (18-40), middle (41-55), and older (56 plus) age. The
use of median split variables has been critically discussed in
the literature (see eg, Iacobucci et al [61]), with a major critique
being the loss of information. In our case, the loss of information
can be justified with the illustrative capacity of Kaplan-Meier
survival curves and the following use of a multivariate Cox
proportional hazards regression. Fourth, as the sample size was
an outcome in itself, we did not perform an a priori sample size
calculation. With a sample size (N) of 100, we had a power of
0.63 in the Cox proportional hazards regression for the main
effect (OR 2.16) of gender as a predictor. For a power of 0.8, a
sample size (N) of 150 would be necessary.
Conclusions and Future Research
The acceptable adherence to the intervention and the generally
positive feedback by patients indicate that this app intervention
is feasible. Suggestions for improvement by patients indicate
that patients’ needs are heterogeneous, which should be taken
into account when developing other mHealth interventions. Due
to the acceptable adherence and positive feedback by cancer
patients, mindfulness and relaxation mHealth interventions
might be promising supportive interventions, also for cancer
patients with elevated depressive symptoms.
To further prove the importance of mindfulness and relaxation
mHealth interventions for cancer patients, future research needs
to investigate their effectiveness. As the dose potentially
influences the effectiveness of mindfulness and relaxation
interventions, future research should also look into
dose-response relationships between the time spent exercising
with the app and health outcomes. Knowledge of such a
dose-response relationship could be of use to guide subsequent
studies regarding intervention duration and practice
recommendation for patients. This study suggests that variability
across patients in weekly app use is large. About half of the
patients used the app exercises continuously over 10 weeks and
therefore adhered to the intervention. These interindividual
differences in the use of app exercises underline the importance
to take adherence into account when analyzing effectiveness
data. Furthermore, these interindividual differences on adherence
bring up the question if mindfulness- and relaxation-based
mHealth interventions are better suited for specific patient
groups (eg females, patients with higher depressive symptoms).
In turn, male patients or patients with less distress might not be
in need of such interventions or might require additional
motivational interventions.
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